SUBSCRIBE TO RSS
Purdue Exponent highlights work by Heffter President
Second part of special issue on psychedelics and addiction published by OPEN
Magic mushrooms and the healing trip | The New Yorker
Matthew Johnson: "Psychedelic therapy may become available in a decade"
A New Understanding: The Science of Psilocybin | New York Open Center
Could a psychedelic drug prevent asthma? | Science World Report
The government should support psychedelic research | THE WEEK
The Trip Treatment | The New Yorker
Current Drug Abuse Reviews devotes issue to psychedelics
Day Tripping: Benefits Seen in Psychedelics | Newsweek
Return to Heffter News
Lame puns aside Â Alexander Zaitchik extensive article on psychedelics in SALON is a fine overview concerning their history and present medical status. Prominently featured are Heffter researchers, Dr. Stephen Ross, Dr. Roland Griffiths and Dr. Charles Grob.
To enjoy the full flashback: Â http://life.salon.com/2011/09/28/the_new_lsd_cure/singleton/